All Wales Medicines Strategy Group Final Appraisal Report - Raltegravir (Isentress) in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (HIV-1) infection in treatment-experienced adult patients with evidence of HIV-1 replication despite ongoing antiretroviral therapy.
Research output: Book/Report › Commissioned report
| Original language | English |
|---|---|
| Publisher | Unknown |
| Commissioning body | NHS Wales |
| Edition | 2008 |
| Publication status | Published - 1 Jan 2008 |